In this peer discussion webinar, we will provide an overview of key clinical indications for optomap® ultra-widefield retinal imaging and explore options for implementing the technology in ophthalmology practices. Your peers will interactively discuss the advantages they have experienced using ultra-widefield. Each will present their own cases, discuss their decision making and provide practical tips on how to make the most of ultra-widefield with multi-modality for your daily practice. A brief roundtable discussion will wrap up the session.
Mr Ayman Saeed (Hermitage Medical Clinic, Dublin)
UWF Multi-modality Retinal Imaging in the Private Ophthalmology Clinic
Mr Ashish Patwardhan (Royal Cornwall Hospital NHS Foundation Trust)
UWF Multi-modality Retinal Imaging in Virtual Diabetic Retinopathy Clinic
Mr Abdelsattar Farrag (Royal Bolton NHS Foundation Trust)
UWF Multi-modality Retinal Imaging for the Management of Uveitis
Miss Vasuki Sivagnanavel (Kingston Hospital NHS Foundation Trust)
UWF Multi-modality Retinal Imaging During the Pandemic and Beyond
optomap clinical value is proven in over 2,000 peer-reviewed published studies. optomap imagingimproves practice flow and patient engagement. It drives increased patient satisfaction and decreases patient visit time by 33%10. Clinics with optomap see more patients11,12,13, and find 66% more pathology compared to practices which haven’t invested in ultra-widefield technology. optomap guided OCT imaging impacted clinical decision making in 84% of cases14.
10. Lin, et al; Retina, 2021. 11. Tornambe; US Ophthalmic Review, 2017. 12. Assil et al; US Ophthalmic Review, 2017. 13. Boyer; Retina Today, 2021. 14. Feasibility of peripheral OCT imaging using a novel integrated SLO ultra-widefield imaging swept-source OCT device. International Ophthalmology, 2021.
